CATALYST DOSSIER · UPDATED 2026-11-05
$CC
materials · convergence -17 · conviction AVOID
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $CC?
Quantitative
Net Income (CY2026Q2) : $-274.0M (+27.9% YoY)
Catalysts
Multi-spoke convergence : 5 convergent signals fired: alpha, finra_short, auto_macro_adp_payrolls, auto_macro_durable_goods, auto_macro_fx_rates
Risks
Auditor change / restatement : valuation_allowance on
Financial restatement : 1 restatement filing(s); investor confidence risk
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Sympathy basket (cerebro)
TAP via staples r=+0.97 sympathetic (score 9)
CHSN via staples r=+0.97 sympathetic (score 5)
VCTR via financials r=+0.84 sympathetic (score 19)
FCPT via financials r=+0.84 sympathetic (score 15)
HYFM via consumer r=+0.82 sympathetic (score 8)
LCII via consumer r=+0.82 sympathetic (score 8)
Signals Firing
alpha finra_short auto_macro_adp_payrolls auto_macro_durable_goods auto_macro_fx_rates
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-09-10 sec_clean_gappers +1.4% -0.3% — 2026-09-10 sec_top_gappers +1.4% -0.3% — 2026-09-10 sec_top_moat_emerging +1.4% -0.3% — 2026-09-09 sec_clean_gappers +2.7% +0.2% ✓ hit 2026-09-09 sec_top_gappers +2.7% +0.2% ✓ hit 2026-09-09 sec_top_moat_emerging +2.7% +0.2% ✓ hit
Lifetime: 3/6 wins · hit-rate 50.0% on +2% intraday
Sympathy Basket TAP via staples · score 9 CHSN via staples · score 5 VCTR via financials · score 19 FCPT via financials · score 15 HYFM via consumer · score 8 LCII via consumer · score 8
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.